You have read all your free articles, to continue reading subscribe to read the rest of this content.
AstraZeneca announced that Cambridge City Council has granted planning permission for the company’s new global research and development center and corporate headquarters in the city. The facility will be located on the Cambridge Biomedical Campus and will be home to approximately 2,000 employees. Already a subscriber Login You have read…
Medivir together with the originators of remetinostat, and TetraLogic Pharmaceuticals Corporation and the Leukemia & Lymphoma Society ("the stakeholders") have restructured and streamlined the financial obligations for remetinostat. The purpose of the new agreement is to create improved businAlready a subscriber Login You have read all your free articles, to…
Amgen and Nuevolution have entered into a multiple target research collaboration to develop and commercialize novel therapeutics in the areas of oncology and neuroscience. Nuevolution will apply its Chemetics drug discovery platform to discover and advance potential therapeutics of interest to AmAlready a subscriber Login You have read all your…
The CDMO company has announced the launch of its standalone serialization service ahead of the introduction of the EU Falsified Medicines Directive (FMD). The new service is designed to offer pharmaceutical companies access to Recipharm’s serialization capabilities as a standalone service due tAlready a subscriber Login You have read all…
